Abstract
Introduction and hypothesis
Health state utility values estimate an individual’s valuation of their health-related quality of life. Despite prevalence of recurrent urinary tract infections (rUTIs), the health state utility value of rUTIs is unknown. The primary aim was to determine the utility value of rUTIs using the standard gamble (SG). The secondary aim was to compare the SG utility value with that derived from the EuroQol 5 dimensions (EQ-5D) and visual analog scale (VAS). We hypothesized that a utility value would be successfully derived from the SG and would differ from that derived using the EQ-5D and VAS.
Methods
Nonpregnant, adult English-speaking female patients with a diagnosis of rUTI were recruited and completed the EQ-5D, VAS, and SG (n = 25). Utility values were evaluated using Wilcoxon signed-rank tests and Spearman’s rho correlation.
Results
Health state utility values varied depending on the assessment tool used: EQ-5D 0.76 (IQR 0.52), VAS 0.70 (IQR 0.30), and SG 0.85 (IQR 0.25). There were differences between VAS and the other two assessment methods (p<0.001), as well as between EQ-5D and SG (p=0.013). Spearman correlation demonstrated a moderately positive correlation between EQ-5D and VAS values (r(25) = 0.59, p=0.0019).
Conclusions
Our data suggest that 0.85 reflects the true health state utility value of rUTIs among nonpregnant adult English-speaking women. The utility value for recurrent UTIs is worse (lower) than that previously published for nonrecurrent UTIs, reflecting the ability of the SG to convey the compounding impact of recurrent disease. In this study, neither the EQ-5D nor the VAS produced results consistent with those found using the SG, which suggests limited validity in this population.
Similar content being viewed by others
Data Availability
Data available on request from the authors.
References
Bermingham SL, Ashe JF. Systematic review of the impact of urinary tract infections on health-related quality of life. BJU Int. 2012;110(11 Pt C):E830–6. https://doi.org/10.1111/j.1464-410X.2012.11337.x.
Kattan MW. Comparing treatment outcomes using utility assessment for health-related quality of life. Oncology (Williston Park). 2003;17(12):1687–93; discussion 1693–4, 1697, 1701.
Nemes S, Rolfson O, Garellick G. Development and validation of a shared decision-making instrument for health-related quality of life one year after total hip replacement based on quality registries data. J Eval Clin Pract. 2018;24(1):13–21. https://doi.org/10.1111/jep.12603.
Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU Guideline. J Urol. 2019;202(2):282–9. https://doi.org/10.1097/JU.0000000000000296.
Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4(5). https://doi.org/10.1128/microbiolspec.UTI-0002-2012
Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):107–17. https://doi.org/10.1080/14737167.2017.1359543.
Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172.
Armstrong N, Vale L, Deverill M, et al. Surgical treatments for men with benign prostatic enlargement: cost effectiveness study. BMJ. 2009;338:b1288. https://doi.org/10.1136/bmj.b1288.
Moghalu O, Stoffel JT, Elliott S, et al. Psychosocial aspects of health-related quality of life and the association with patient-reported bladder symptoms and satisfaction after spinal cord injury. Spinal Cord. 2021;59(9):987–96. https://doi.org/10.1038/s41393-020-00609-x.
Vogel LC, Chlan KM, Zebracki K, Anderson CJ. Long-term outcomes of adults with pediatric-onset spinal cord injuries as a function of neurological impairment. J Spinal Cord Med. 2011;34(1):60–6. https://doi.org/10.1179/107902610X12883422813787.
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13. https://doi.org/10.1016/j.idc.2013.09.003.
Drummond MFSM, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 4th ed. Oxford, New York: Oxford University Press; 2015.
Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol. 2002;86(5):493–6. https://doi.org/10.1136/bjo.86.5.493.
Yee LM, Kaimal AJ, Houston KA, et al. Mode of delivery preferences in a diverse population of pregnant women. Am J Obstet Gynecol. 2015;212(3):377.e1–24. https://doi.org/10.1016/j.ajog.2014.10.029.
Einstein MH, Rash JK, Chappell RJ, Swietlik JM, Hollenberg JP, Connor JP. Quality of life in cervical cancer survivors: patient and provider perspectives on common complications of cervical cancer and treatment. Gynecol Oncol. 2012;125(1):163–7. https://doi.org/10.1016/j.ygyno.2011.10.033.
Kalyanaraman R, Demtchouk V, Iyer V, Patterson D. Determining the health state utility value of urinary tract infection in women. Female Pelvic Med Reconstr Surg. 2019;25(2):185–7. https://doi.org/10.1097/SPV.0000000000000696.
Manyak MJ, Ackerman SJ, Blute ML, et al. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy. J Endourol. 2002;16(1):51–6. https://doi.org/10.1089/089277902753483736.
Patterson D, Geisler BP, Morse A. Determining health-related quality of life and health state utility values of urinary incontinence in women. Female Pelvic Med Reconstr Surg. 2011;17(6):305–7. https://doi.org/10.1097/SPV.0b013e31823c040.
Agency for Healthcare Research and Quality. U.S. valuation of the EuroQol EQ-5 Health States, https://archive.ahrq.gov/professionals/clinicians-providers/resources/rice/EQ5Dproj.html. Accessed March 2022
Arnold D, Girling A, Stevens A, Lilford R. Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. BMJ. 2009;339:2688. https://doi.org/10.1136/bmj.b2688.
Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making. 2001;21(4):329–34. https://doi.org/10.1177/0272989X0102100408.
Author information
Authors and Affiliations
Contributions
M. Le Neveu: project development, data collection, manuscript writing; R. Nicholson: data collection, manuscript writing; P. Agrawal: data collection, manuscript writing; M. Early: data collection, manuscript writing; D. Patterson: project development, manuscript editing.
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Le Neveu, M., Nicholson, R., Agrawal, P. et al. Determining health-related quality of life and health state utility values of recurrent urinary tract infections in women. Int Urogynecol J 34, 1831–1835 (2023). https://doi.org/10.1007/s00192-023-05468-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-023-05468-7